Deformation variation of buried DN50 PE pipeline with different buried depths. by Pengcheng Li (123281)

Luteoloside decreases intracellular ROS. by Shao-hua Fan (527624)

Leaf chlorophyll <i>a</i>, <i>b</i>, <i>a/b</i>, total chlorophyll, proline and Glycinebetaine (GB) contents of two cultivars of cauliflower (<i>Brassica oleracea</i> L.) plants fo... by Munifa Jabeen (12634746)

BMT decreases HFD-induced weight gain associated with decreased preadipocyte number and insulin secretion by Saeed Katiraei (3956147)

Relationships between the unconfined compressive strength and destructive strains εf and E₅₀: (a) Relationship between the destructive strain εf and peak strength q<sub>... by Xiaoyan Ding (291429)

Decrease in blood pressure by PP2, a Src inhibitor in <i>Csk</i>^+/- mice. by Hyeon-Ju Lee (796527)

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Inhibition of GATA2 in clinical primary AML cells decreased the survival rate during chemo treatment. by Li Yang (6520)

Selection for West Nile virus populations with decreased susceptibility to ribavirin. by Greta A. Van Slyke (761322)

Probabilities of a decrease in coral cover by the years 2050 and 2099 relative to the year 2000. by Ron K. Hoeke (226302)

“…Note the 2099 “less resilient” case is the probability of a 99% or greater decrease in coral cover, other columns are for 50% or greater decrease.…”

Calyculin A-induced decrease of tyrosine-monophosphorylated ERK2 at high cell density. by Noriyuki Kawabata (3391739)

Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

“…Consequently, <i>TA</i> no longer decreases but may even increase with price (A, lower panel). …”

Cytotoxicity (as of %Control) IC₅₀ value (mean ±SD in µM) of the tested compounds vs. Positive controls Cisplatin and doxorubicin against gastrointestinal and colorectal... by MohammedBashar Al-Qazzan (22439236)

CD107a-, IFNγ- and MIP 1β-producing Vγ9Vδ2 T-cell subsets decrease in HIV+ patients. by Rita Casetti (608635)

The ATR-CHK1 inhibitor AZD6738 decreases HBV cccDNA level. by Kaitao Zhao (3617825)

TUDCA decreases ER stress in HOX neonatal rat lungs. by Kirkwood A. Pritchard Jr. (13449794)

“…(<b>C</b>) In IHC stain, P-IRE1α levels are decreased (40.8±3.5 A.U. <i>vs</i> 53.1±5.0 A.U., p<0.001, n = 6, 3 for each sex) in chronic hyperoxia exposed neonatal rat lungs by TUDCA. …”

LOH resulting in 189R/R produces a strong decrease in drug susceptibility. by Pétra Vande Zande (17628246)